caplacizumab
Drug Details
- Generic Name
- caplacizumab
- Brand Names
- Cablivi
- Application Number
- BLA761112
- Sponsor
- Patheon Italia S.p.A.
- NDC Codes
- 2
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, KIT
- Routes
- N/A
- Active Ingredients
- CAPLACIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE CABLIVI is indicated for the treatment of adult and pediatric patients 12 years of age and older with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy. CABLIVI is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult and pediatric patients 12 years of age and older with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy. ( 1 )